On Feb. 10, Valeant Pharmaceuticals International Inc. bought the rights to a pair of life-saving heart drugs. The same day, their list prices rose by 525% and 212%.
Neither of the drugs, Nitropress or Isuprel, was improved as a result of costly investment in lab work and human testing, Valeant said. Nor was manufacture of the medicines shifted to an expensive new plant. The big change: the drugs’ ownership.
“Our duty is to our shareholders and to maximize the value” of the products that Valeant sells, said Laurie Little, a company spokeswoman. “Sometimes pricing comes into it, sometimes volume comes into it.”
More pharmaceutical companies are buying drugs that they see as undervalued, then raising the prices. It is one of a number of industry tactics, along with companies regularly upping the prices of their own older medicines and launching new treatments at once unheard of sums, driving up the cost of drugs.
Long-term-hospital executives sometimes pursued that goal for financial reasons rather than medical ones, say doctors, nurses and former long-term-hospital employees interviewed by the Journal.
The Journal analysis of claims Medicare paid from 2008 through 2013 found long-term hospitals discharged 25% of patients during the three days after crossing thresholds for higher, lump-sum payments. That is five times as many patients as were released the three days before the thresholds.
23andMe is a DNA analysis service providing information and tools for individuals to learn about and explore their DNA. The name 23andMe refers to the 23 pairs of chromosomes that make up each individual’s genome. Order the $99 kit from the online store. Spit into a collection device for about 15 minutes. Send it in. Wait 4-6 weeks. Get fascinating details about your DNA and what it means.
"MedlinePlus is the National Institutes of Health's Web site for patients and their families and friends. Produced by the National Library of Medicine, it brings you information about diseases, conditions, and wellness issues in language you can understand. MedlinePlus offers reliable, up-to-date health information, anytime, anywhere, for free."
"Drug information guide and health resources for consumers from the publishers of the Physicians' Desk Reference. Information on interactions, side effects, symptoms, treatment, screening, approvals, and more."
It's no longer practical to allow comments. Too much spam. Post comments by tweeting to me @danielfishman. If you want to be notified of site updates use the comments form and send me an email address. Thanks!